KOD Kodiak Sciences Inc
$91.32▲ +1.92%
Healthcare
Other
After hours
$90.82▼ -0.54%
Oct 27, 4:15 PM ET
Volume 1.01M
Avg Volume (10D) 1.14M
Key Metrics & Fundamentals
Market Cap
$5.74B
P/E Ratio
–
Div Yield
0.00%
52W Range
15.83 - 104.00
% vs 50 MA
51.69%
% vs 200 MA
122.54%
RSI-14
61.9
MACD Histogram
-2.0600
Beta (1Y vs SPY)
-0.11
Free Cash Flow
-$46.59M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$60.65M
COGS
–
Operating Exp
$66.84M
Operating Income
-$66.84M
EBIT
-$66.84M
Pretax Income
-$65.64M
Net Income
-$65.64M
EPS (Diluted)
-1.05
Price & Volume History
Loading chart…
Recent News
Can Zenkuda's Multi-Indication Potential Drive KOD Stock Higher?
Zacks · Oct 19, 2026 8:10 AM ET
Kodiak Sciences (KOD) Could Be 7% Overvalued Following Late Stage Data Update
Simply Wall St. · Oct 8, 2026 3:12 PM ET
Kodiak Sciences (KOD) Stock Trades At A Premium On DAYBREAK Trial News
Simply Wall St. · Oct 8, 2026 11:13 AM ET
Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026
PR Newswire · Oct 7, 2026 7:00 AM ET
Kodiak Sciences Stock Pick of the Week at Smart Insider Following Insider Share Purchase
MT Newswires · Oct 6, 2026 9:40 AM ET
Kodiak Sciences’ Two Wet AMD Treatments Match Aflibercept in Phase III Study
MarketBeat · Oct 2, 2026 2:02 PM ET
This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking
BioPharma Dive · Oct 2, 2026 11:00 AM ET
Kodiak Sciences More Than Doubles on Eye Disease Trial Results
Barchart · Oct 1, 2026 10:57 AM ET
A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?
24/7 Wall St. · Sep 30, 2026 8:05 AM ET
This is the top biotech stock pick from B Riley Securities
Investing.com · Sep 29, 2026 5:24 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See KOD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.